IDEXX Laboratories, Inc. (IDXX)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
As of 04:00PM EST. Market open.
Currency in USD
Valuation Measures4
| Market Cap (intraday) | N/A |
| Enterprise Value | N/A |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 0.94 |
| 52-Week Change 3 | N/A |
| S&P500 52-Week Change 3 | N/A |
| 52 Week High 3 | 706.95 |
| 52 Week Low 3 | 455.23 |
| 50-Day Moving Average 3 | 600.49 |
| 200-Day Moving Average 3 | 616.23 |
Share Statistics
| Avg Vol (3 month) 3 | 401.68k |
| Avg Vol (10 day) 3 | 531.42k |
| Shares Outstanding 5 | 84.79M |
| Implied Shares Outstanding 6 | N/A |
| Float 8 | 83.93M |
| % Held by Insiders 1 | 0.94% |
| % Held by Institutions 1 | 86.58% |
| Shares Short (Dec. 14, 2021) 4 | 886.02k |
| Short Ratio (Dec. 14, 2021) 4 | 2.34 |
| Short % of Float (Dec. 14, 2021) 4 | 1.18% |
| Short % of Shares Outstanding (Dec. 14, 2021) 4 | 1.04% |
| Shares Short (prior month Nov. 14, 2021) 4 | 699.61k |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | N/A |
| Trailing Annual Dividend Yield 3 | N/A |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | N/A |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor 2 | 2:1 |
| Last Split Date 3 | Jun. 15, 2015 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Dec. 30, 2020 |
| Most Recent Quarter (mrq) | Sep. 29, 2021 |
Profitability
| Profit Margin | 24.14% |
| Operating Margin (ttm) | 29.28% |
Management Effectiveness
| Return on Assets (ttm) | 25.88% |
| Return on Equity (ttm) | 126.53% |
Income Statement
| Revenue (ttm) | 3.14B |
| Revenue Per Share (ttm) | 36.73 |
| Quarterly Revenue Growth (yoy) | 12.30% |
| Gross Profit (ttm) | 1.57B |
| EBITDA | 1.02B |
| Net Income Avi to Common (ttm) | 756.86M |
| Diluted EPS (ttm) | 8.72 |
| Quarterly Earnings Growth (yoy) | 19.80% |
Balance Sheet
| Total Cash (mrq) | 145.2M |
| Total Cash Per Share (mrq) | 1.71 |
| Total Debt (mrq) | 963.19M |
| Total Debt/Equity (mrq) | 127.50 |
| Current Ratio (mrq) | 1.48 |
| Book Value Per Share (mrq) | 8.89 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 764.52M |
| Levered Free Cash Flow (ttm) | 568.77M |
